Exploratory Study to Evaluate an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity

NCT01691560 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Dentine Hypersensitivity

Interventions

DRUG: 5% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice
DRUG: 0% calcium sodium phosphosilicate/sodium monofluorophosphate dentifrice
DRUG: Sodium monofluorophosphate dentifrice
DRUG: Sodium fluoride dentifrice

Sponsor

GlaxoSmithKline

Collaborators

[object Object]